4 results match your criteria: "Portuguese Institute of Cancer[Affiliation]"
Eur J Gastroenterol Hepatol
November 2007
Gastroenterology Department, Lisbon Portuguese Institute of Cancer of Francisco Gentil, EPE.
(Table is included in full-text article.)Barrett's oesophagus results from the replacement of the normal squamous lining of the oesophagus by a columnar epithelium. It is the sole known premalignant condition for oesophageal adenocarcinoma.
View Article and Find Full Text PDFClin Transl Oncol
June 2006
Department of Head and Neck Surgery, Portuguese Institute of Cancer, Lisbon, Portugal.
Background: Medullary thyroid carcinoma (MTC) is a rare development of thyroid cancer with a no negligible mortality rate. Our aim was to determine factors that predict outcome in patients with MTC.
Methods: We reviewed the records of all patients with MTC (n=56) who underwent treatment at our institution between January 1990 and December 2000.
Clin Transl Oncol
May 2005
Department of Surgery, Portuguese Institute of Cancer, Lisbon, Portugal.
The diagnostic usefulness of sentinel lymph node biopsy (SLNB) has been well established, but its therapeutic value remains unproven. First introduced by Morton and colleagues, the SLNB procedure is now widely available, and markedly enhances our ability to pathologically stage the regional nodes. Although the SLN status is acknowledged as the most powerful indicator of prognosis in melanoma, there is no evidence to-date, of survival advantage for complete lymphadenectomy in SLN-positive patients.
View Article and Find Full Text PDFClin Transl Oncol
July 2005
Department of Surgery, Portuguese Institute of Cancer, Lisbon, Portugal.
Introduction: Breast cancer with metastatic sentinel lymph nodes (SLN) may have clinico-pathologic factors associated with the presence of positive non-sentinel axillary nodes (NSLN). The aim of the present study was to determine factors that predict involvement of NSLN in breast cancer patients with positive SLN.
Material And Methods: A prospective database search identified 80 patients who underwent SLN biopsy for invasive breast cancer between January 1999 and August 2002.